Literature DB >> 9395490

A new mechanism-based radical intermediate in a mutant R1 protein affecting the catalytically essential Glu441 in Escherichia coli ribonucleotide reductase.

A L Persson1, M Eriksson, B Katterle, S Pötsch, M Sahlin, B M Sjöberg.   

Abstract

The invariant active site residue Glu441 in protein R1 of ribonucleotide reductase from Escherichia coli has been engineered to alanine, aspartic acid, and glutamic acid. Each mutant protein was structurally and enzymatically characterized. Glu441 contributes to substrate binding, and a carboxylate side chain at position 441 is essential for catalysis. The most intriguing results are the suicidal mechanism-based reaction intermediates observed when R1 E441Q is incubated with protein R2 and natural substrates (CDP and GDP). In a consecutive reaction sequence, we observe at least three clearly discernible steps: (i) a rapid decay (k1 >/= 1.2 s-1) of the catalytically essential tyrosyl radical of protein R2 concomitant with formation of an early transient radical intermediate species, (ii) a slower decay (k2 = 0.03 s-1) of the early intermediate concomitant with formation of another intermediate with a triplet EPR signal, and (iii) decay (k3 = 0.004 s-1) of the latter concomitant with formation of a characteristic substrate degradation product. The characteristics of the triplet EPR signal are compatible with a substrate radical intermediate (most likely localized at the 3'-position of the ribose moiety of the substrate nucleotide) postulated to occur in the wild type reaction mechanism as well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395490     DOI: 10.1074/jbc.272.50.31533

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  High-field EPR detection of a disulfide radical anion in the reduction of cytidine 5'-diphosphate by the E441Q R1 mutant of Escherichia coli ribonucleotide reductase.

Authors:  C C Lawrence; M Bennati; H V Obias; G Bar; R G Griffin; J Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Computational studies on class I ribonucleotide reductase: understanding the mechanisms of action and inhibition of a cornerstone enzyme for the treatment of cancer.

Authors:  Susana Pereira; Nuno M F S A Cerqueira; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  Eur Biophys J       Date:  2005-10-29       Impact factor: 1.733

3.  Dehydration of ribonucleotides catalyzed by ribonucleotide reductase: the role of the enzyme.

Authors:  Nuno M F S A Cerqueira; Pedro Alexandrino Fernandes; Leif A Eriksson; Maria João Ramos
Journal:  Biophys J       Date:  2005-12-16       Impact factor: 4.033

4.  The active form of Chlamydia trachomatis ribonucleotide reductase R2 protein contains a heterodinuclear Mn(IV)/Fe(III) cluster with S = 1 ground state.

Authors:  Wei Jiang; J Martin Bollinger; Carsten Krebs
Journal:  J Am Chem Soc       Date:  2007-05-27       Impact factor: 15.419

5.  Ribonucleotide reductases in the twenty-first century.

Authors:  J Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Selenocysteine Substitution in a Class I Ribonucleotide Reductase.

Authors:  Brandon L Greene; JoAnne Stubbe; Daniel G Nocera
Journal:  Biochemistry       Date:  2019-12-06       Impact factor: 3.162

7.  Molecular Basis of C-N Bond Cleavage by the Glycyl Radical Enzyme Choline Trimethylamine-Lyase.

Authors:  Smaranda Bodea; Michael A Funk; Emily P Balskus; Catherine L Drennan
Journal:  Cell Chem Biol       Date:  2016-09-24       Impact factor: 8.116

8.  Glutamate 52-β at the α/β subunit interface of Escherichia coli class Ia ribonucleotide reductase is essential for conformational gating of radical transfer.

Authors:  Qinghui Lin; Mackenzie J Parker; Alexander T Taguchi; Kanchana Ravichandran; Albert Kim; Gyunghoon Kang; Jimin Shao; Catherine L Drennan; JoAnne Stubbe
Journal:  J Biol Chem       Date:  2017-04-04       Impact factor: 5.157

9.  RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia.

Authors:  Josephine Aimiuwu; Hongyan Wang; Ping Chen; Zhiliang Xie; Jiang Wang; Shujun Liu; Rebecca Klisovic; Alice Mims; William Blum; Guido Marcucci; Kenneth K Chan
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

10.  In vivo assay for low-activity mutant forms of Escherichia coli ribonucleotide reductase.

Authors:  Monica Ekberg; Pernilla Birgander; Britt-Marie Sjöberg
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.